Stocktoria

HCW Biologics Inc. HCWB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-07-20 · LEI

HCW Biologics Inc. statistics & valuation

Market cap$7.4M
P / B2.7×
Net margin-14677.1%
FCF margin-24693.2%
Net cash$2.0M
Enterprise value USD$5.4M
Return on capital-380.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-141.50% -221.70% -879.50% -1169.70% -14677.10% 202020212022202320242025
Gross margin (%)
38.50% 19.70% 37.40% 20.00% 202020212022202320242025
Operating margin (%)
-142.10% -224.30% -905.00% -1147.60% -24270.70% 202020212022202320242025
Return on equity (%)
-25.10% -39.80% -185.70% -287.90% 202020212022202320242025
Shares outstanding
18.8M 35.8M 35.9M 969825 2.1M 202020212022202320242025
Net debt ($)
-$11.7M -$15.9M $2.7M $2.7M -$2.0M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-37.70% -24.00% -31.80% -87.70% -99.30% -32.50% 202020212022202320242025
Free cash flow margin (%)
-259.00% -307.40% -1010.50% -564.50% -24693.20% 202020212022202320242025
Debt / equity (×)
0.00× 0.17× 0.47× 0.00× 202020212022202320242025
EPS ($)
-$0.69 -$0.42 -$0.70 -$30.96 -$10.63 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin20.0%37.4%19.7%38.5%——
Operating margin-24270.7%-1147.6%-905.0%-224.3%—-142.1%
Net margin-14677.1%-1169.7%-879.5%-221.7%—-141.5%
FCF margin-24693.2%-564.5%-1010.5%-307.4%—-259.0%
Return on assets-32.5%-99.3%-87.7%-31.8%-24.0%-37.7%
Return on equity-287.9%443.5%-185.7%-39.8%-25.1%34.7%
Debt / equity0.00×-1.09×0.47×0.17×0.00×—
Current ratio0.110.190.7311.5217.4412.14

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.